Page last updated: 2024-12-06
2-amino-5-chloropyridine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 66174 |
SCHEMBL ID | 77304 |
MeSH ID | M0282936 |
Synonyms (58)
Synonym |
---|
(5-chloro-pyridin-2-yl)-amine |
1072-98-6 |
pyridine, 2-amino-5-chloro- |
5-chloro-2-aminopyridine |
2-amino-5-chloropyridine , |
2-pyridinamine, 5-chloro- |
nsc26283 |
nsc-26283 |
5-chloro-2-pyridinamine |
5-chloropyridin-2-amine |
inchi=1/c5h5cln2/c6-4-1-2-5(7)8-3-4/h1-3h,(h2,7,8 |
2-amino-5-chloropyridine, 98% |
STK398098 |
AC-2429 |
A0837 |
AKOS000119653 |
ai3-52448 |
5-chloro-2-pyridylamine |
nsc 26283 |
einecs 214-020-4 |
5-chloropyridin-2-ylamine |
BP-12769 |
FT-0611162 |
5-chloro-pyridin-2-ylamine |
PS-3640 |
AM20050652 |
AB00712 |
AB2782 |
2-amino5-chloropyridine |
SCHEMBL77304 |
2-amino-5-chloro pyridine |
2-amino-5-chloropyrdine |
2-amino-5-chloro-pyridine |
2-amino-5-chloropyridin |
2-amino-5-cloropyridine |
5-chloropyridine-2-amine |
2-amino-5chloropyridine |
Q-103358 |
AG-617/02036012 |
STR00702 |
DTXSID0073247 |
AKOS025397221 |
mfcd00006324 |
STL453491 |
5-chloropyridin-2(1h)-imine |
F0001-0149 |
2-amino-5-chloropyridine, purum, >=98.0% (nt) |
2-amino-5-chloropyridine, british pharmacopoeia (bp) reference standard |
SY001089 |
CS-W018533 |
CCG-325545 |
BCP23345 |
5-chloro-2-pyridinamine;5-chloropyridin-2-amine |
EN300-19819 |
2-amino-5-chloropyridine--d3 |
J8TAP6NFD4 |
rp-26695 |
Z104475596 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 8 (72.73) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 32.80
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (32.80) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 14 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |